Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/14/2007EP1761328A1 Product comprising a beta-lactam antibiotic
03/14/2007EP1761283A2 Biodegradable drug-polymer delivery system
03/14/2007EP1761282A2 Preparation of macromolecular conjugates by four-component condensation reaction
03/14/2007EP1761281A1 Method for treating abnormal cell growth
03/14/2007EP1761280A1 Combinations comprising antimuscarinic agents and pde4 inhibitors
03/14/2007EP1761279A1 Combinations comprising antimuscarinic agents and pde4 inhibitors
03/14/2007EP1761270A1 Estrogen receptor modulators
03/14/2007EP1761269A1 Use of meloxicam in veterinary medicine for the treatment of inflammatory painful diseases
03/14/2007EP1761268A2 Pyrrolotriazine kinase inhibitors
03/14/2007EP1761267A1 Diazabicyclic histamine-3 receptor antagonists
03/14/2007EP1761266A2 Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
03/14/2007EP1761265A2 A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
03/14/2007EP1761264A1 Treatment with irinotecan (cpt-11) and an egfr-inhibitor
03/14/2007EP1761263A1 Treatment of neuropathic pain, fibromyalgia or rheumatoid arthritis
03/14/2007EP1761262A1 Marine compounds with calcium channel blocking properties for the treatment of cognitive or neurodegenerative diseases
03/14/2007EP1761261A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions
03/14/2007EP1761260A1 Compression coated tablet comprising sumatriptan
03/14/2007EP1761259A2 Topical formulations for treating allergic diseases
03/14/2007EP1761258A1 Hypoestoxides, derivatives and agonists thereof for use as stent-coating agents
03/14/2007EP1761257A1 Use of acetyl l-carnitine for the preparation of a medicine for the treatment of neuropathic pain in diabetic patients
03/14/2007EP1761256A1 Cla-enriched milkfat and uses thereof
03/14/2007EP1761255A1 Decreasing brain neuronal glutamate levels using alpha-keto branched chain amino acids
03/14/2007EP1761254A1 Improvement of image quality in the eye
03/14/2007EP1761253A2 Hyaluronic acid in the enhancement of lens regeneration
03/14/2007EP1761252A1 Matrix-controlled transdermal therapeutic system based on an adhesive for administering norelgestromin or the combination thereof with an estrogen
03/14/2007EP1761250A1 Oral delivery system
03/14/2007EP1761247A1 Injectable pharmaceutical suspension comprising posaconazole
03/14/2007EP1761243A1 Tobacco alkaloid releasing chewing gum
03/14/2007EP1761242A2 Film-shaped estriol-containing medicament for oral administration
03/14/2007EP1761233A1 Preventing shin damage
03/14/2007EP1761231A1 Dispenser for progestin used for acute and maintenance treatment of dub
03/14/2007EP1694318B1 (s)-2-n-propylamino-5-hydroxytetralin as a d3-agonist
03/14/2007EP1658055B1 Form of administration secured against misuse
03/14/2007EP1631279A4 Combination therapy for the treatment of neoplasms
03/14/2007EP1581165B1 Factor viia inhibiting compounds
03/14/2007EP1565433B1 Novel ligands that are antagonists of rar receptors, process for preparing them and use thereof in human medicine and in cosmetics
03/14/2007EP1562936B1 Therapeutic piperazine compounds
03/14/2007EP1526839B1 Oral pharmaceutical forms of liquid drugs having improved bioavailability
03/14/2007EP1517895B1 8-(biaryl) quinoline pde4 inhibitors
03/14/2007EP1515949B1 Mitotic kinesin inhibitors
03/14/2007EP1511728B1 Oxophenyl-cyclohexyl-propanolamine derivatives, production and use thereof in therapeutics
03/14/2007EP1502595B1 An injection made from ixeris sonchifolia for treatment of cardio-cerebral vascular disease and fundus diseases and method of producing thereof
03/14/2007EP1487842B1 An optically acitve pyridine derivative and a medicament containing the same
03/14/2007EP1467706B1 Dermal application system for aminolevulinic acid-derivatives
03/14/2007EP1465629B1 5-ht3 receptor antagonists and methods of use
03/14/2007EP1461063B1 Treatment of glioblastoma with thymosin-alpha 1
03/14/2007EP1450760B1 Itch-relieving cosmetic and dermatological preparations
03/14/2007EP1448235B1 Oral controlled release pharmaceutical compositions of 5,8,14-triazatetracyclo 10.3.1.0(2,11).0(4,9)]-hexadeca-2(11)3,5,7,9-pentaene
03/14/2007EP1447445B1 Probe solution compositions, reactive chip using the same and process for the production thereof
03/14/2007EP1443966B1 Method of preventing or treating benign gynaecological disorders
03/14/2007EP1427394B1 Process for accelerating recovery from trauma by using apoptosis-mimicking synthetic or natural entities
03/14/2007EP1406897B1 Compounds
03/14/2007EP1399152B1 Pharmaceutical composition comprising a lipase inhibitor and a sucrose fatty acid mono-ester
03/14/2007EP1385502B1 Medicament comprising an anhydrous formulation of xanthogenate
03/14/2007EP1372667A4 Compositions for delivering bisphosphonates
03/14/2007EP1347764B1 Gel composition based on alcohol for the treatment of hypogonadism through transscrotal application
03/14/2007EP1337276B1 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor
03/14/2007EP1328507B1 Naphthylsalicylanilides as antimicrobial and antiinflammatory agents
03/14/2007EP1259262B1 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol)
03/14/2007EP1253919A4 Method and compositions for treating an inflammatory disease
03/14/2007EP1244800B1 Rapamycin analogs
03/14/2007EP1242083B1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them
03/14/2007EP1216031B1 Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
03/14/2007EP1212068A4 Method of enhancing the efficacy of anti-tumor agents
03/14/2007EP1178999B1 L-ribo-lna analogues
03/14/2007EP1171101B1 Method for producing a water-insoluble amorphous controlled release matrix
03/14/2007EP1163226B1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity
03/14/2007EP1133318B1 Supramolecular complexes containing therapeutic agents
03/14/2007EP1112057B1 Cosmetic or dermopharmaceutical use of peptides for healing, hydrating and improving skin appearance during natural or induced ageing (heliodermia, pollution)
03/14/2007EP1095947B1 Novel antibacterial compounds
03/14/2007EP1071411B1 Topical immunostimulation to induce langerhans cell migration
03/14/2007EP1067956B1 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
03/14/2007EP1051183B1 Peritoneal dialysis solution containing modified icodextrins
03/14/2007EP1045837B1 Monomeric and dimeric arylisoquinoline alkaloids and derivatives thereof
03/14/2007EP1041978B1 Methods of inactivating bacteria including bacterial spores
03/14/2007EP1040103B1 Anilide derivative, production and use thereof
03/14/2007EP1011637B1 Modulation of drug loading in multivesicular liposomes
03/14/2007EP0998471B1 Substituted heterocyclic compounds, method for preparing and compositions containing same
03/14/2007EP0989978B1 Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors
03/14/2007EP0981328B1 Composition forming an emulsion for a taxoid compound
03/14/2007EP0944648B1 Glp-1 derivatives
03/14/2007CN2877688Y Glycyrrhetic acid kali salt thin film coating tablet
03/14/2007CN1930190A Hyaluronic acid derivative and drug containing the same
03/14/2007CN1930182A Antithrombotic compound
03/14/2007CN1930181A Helix 12 directed pharmaceutical products
03/14/2007CN1930171A 7H-8,9-dihydro-pyrano(2,3-C)imidazo(1,2A)pyridine derivatives and their use as gastric acid secretion inhibitors
03/14/2007CN1930170A Diazabicyclononene and tetrahydropyridine derivatives as renin inhibitors
03/14/2007CN1930164A Process for the preparation of n-([1,2,4]triazolopyrimidin-2-yl)aryl sulfonamides
03/14/2007CN1930163A Novel dichloro-phenyl-pyrido [2,3-d] pyrimidine derivates, their manufacture and use as pharmaceutical agents
03/14/2007CN1930162A Tetrahydropyridoindole derivatives
03/14/2007CN1930161A Hiv整合酶抑制剂 Hiv integrase inhibitors
03/14/2007CN1930160A Hiv整合酶抑制剂 Hiv integrase inhibitors
03/14/2007CN1930159A Novel dicationic imidazo[1,2-a]pyridines and 5,6,7,8,-tetrahydro-imidazo[1,2,-a]pyridines as antiprotozoal agents
03/14/2007CN1930158A New quaternized quinuclidine esters
03/14/2007CN1930156A Oxidized thioether derivatives of styryl-azoles and their use as HER tyrosine kinases inhibitors
03/14/2007CN1930155A Acylaminothiazole derivatives, preparation method thereof and use of same in therapeutics
03/14/2007CN1930154A Ether derivatives, their manufacture and use as pharmaceutical agents
03/14/2007CN1930153A Pentafluorosulfanyl compounds, their manufacture and use as pharmaceutical agents
03/14/2007CN1930152A 1,3-dioxane derivatives and analogues thereof useful in the treatment of I.A. obesity and diabetes
03/14/2007CN1930151A Novel indole derivative for alkylating specific base sequence of DNA and alkylating agent and drug each comprising the same
1 ... 3840 3841 3842 3843 3844 3845 3846 3847 3848 3849 3850 3851 3852 3853 3854 3855 3856 3857 3858 3859 3860 ... 7860